Local ablative radiotherapy for oligometastatic non-small cell lung cancer.

Radiat Oncol J · 2019 · PMC6790793 · PMID 31591862

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The addition of SABR showed a tendency towards better PFS and OS than pembrolizumab treatment alone, although these results did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.